Skin Immunomodulation: Drugs, Antibodies and Vaccines
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 6281
Special Issue Editors
Interests: immunomodulation; skin immunity; bioinformatics
Interests: skin microbiome; acne vaccine; beneficial microbes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Human skin consists of various immune cells and microbes and acts as an active immune organ. Immunity in skin functions as a barrier, which is the first line of innate immune defense against pathogens. Disruption of skin immunity, including dysfunction of immune cells and dysbiotic skin microbiome, can result in various skin diseases. Skin immunomodulation using drugs, antibodies, vaccines, and others provides a new modality for the treatment of skin diseases. These modalities become advanced pharmacotherapeutics of human diseases.
This Special Issue aims to collect manuscripts on research related to drugs, antibodies, vaccines, probiotics, prebiotics, or postbiotics for curing or preventing skin diseases. We will also collect manuscripts on the development of new delivery methods for effective pharmacotherapeutics to the skin. In this Special Issue, original research articles and reviews are welcome.
We look forward to receiving your contributions.
Dr. Huiying Li
Prof. Dr. Eric (Chun-Ming) Huang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- skin immunomodulation
- microbiome
- drugs
- antibodies
- vaccines
- drug delivery